Results in Journal Journal of Clinical Intensive Care and Medicine: 41
(searched for: journal_id:(3334100))
Published: 28 June 2022
Journal of Clinical Intensive Care and Medicine, Volume 7, pp 005-015; https://doi.org/10.29328/journal.jcicm.1001041
Introduction: The world is currently facing the SARS-CoV-2 pandemic with evolving 2nd wave. The COVID-19 patients present most commonly with Severe Acute Respiratory Illness (SARI) in an emergency room with acute onset fever, cough, and breathlessness. However, not all SARI cases as per definition are due to COVID-19 infection, which is well proven in this case series of 113 cases of SARI. This is just the opposite of the other SARI series done in the pre-COVID-19 era. Also, no previous SARI case series data has shown significant association with Diabetes Mellitus, including new-onset diabetes thus figuring out the major Pathophysiological association of COVID-19 with glucose metabolism and has a bearing on the pathogenesis, treatment, and outcome of COVID-19 infection and perpetuity of pandemic of this magnitude. Here we raise concern for the first time about the growing association of an infectious pandemic with the lifestyle disorders which are non-communicable diseases but carry with them the potential of fertile soil for rapidly spreading epidemics. Aim and objective: To find out the etiology, clinical profile, treatment outcome, and mortality rate in different sub-groups of SARI cases in a tertiary care hospital and the incidence of new-onset Diabetes Mellitus in them and to investigate theoretically the hypothesis that maintaining normal glucose metabolism could prevent progression of a mild Flu-like illness (FLI) to a severe form of Severe Acute Respiratory Illness (SARI) and consequent complications such as Cytokine Storm Syndrome and Multi-Organ failure. Design: Retrospective, single-center case series of 113 SARI patients at a tertiary care hospital in Agra India between 1 March- 30 October 2020. Main outcome: The demographics, clinical, pathological, imaging, and treatment outcome data were collected. The SARI cases analyzed were defined as “Severe acute respiratory infections (SARIs) an acute respiratory illness of recent onset (within seven days) manifested by fever (≥ 38 °C), cough and shortness of breath or difficulty in breathing requiring hospitalization and were sub-classified according to the primary etiology producing SARI in them. The findings were compiled and compared. Conclusion: Of the 113 patients of SARI – 32.7% were associated with Diabetes, with 9.74% new-onset Diabetes and 26% previously known Diabetes. This was mainly due to SARS-CoV-2 (24 Diabetics out of 52 COVID-19 cases- 46.1%). The Average hospitalization stay of SARI cases was 10 days with a maximum in SARS-CoV-2 and a minimum stay of 5.22 days in Bacterial Pneumonia and 5.66 days in Koch’s Lungs. The death rate was maximum (4 out of 26) 15.3%. Hospitalized TB/Koch’s Lung patients who presented as SARI and 3.8% in Bacterial Pneumonia, 2.43% in SARS-CoV-2, and < 1% in Sepsis. Those SARI cases who were euglycemic at the time of initial presentation recovered early and carried a good prognosis with less mortality as compared to those who were hyperglycemic on presentation. Also, those FLI cases who maintained euglycemia or did not have any other risk factor which predisposes them to stress (Diabetes, Prolonged fasting, Obesity, major organ disorder, Psychological disorder, and Cancer) did not progress to SARI as the endogenous steroid secretion and sympathetic activation did not occur, the intracellular pH levels remained in the alkaline range. 10.18% of cases developed new-onset diabetes (a total of 11 cases) out of which 10 were in COVID-19. Thus 19.2% incidence of new-onset diabetes in SARS-CoV-2 and a prevalence of 26.9% in SARS-CoV-2, making total diabetes 46.1% in SARS-CoV-2, and out of all SARI cases, 26% of patients developed pulmonary fibrosis with consequent long-term complications. In COVID-19 patients, it was seen only in diabetics SARS CoV-2 male patients, thus no death in non-diabetic females in COVID-19 in this case series.
Published: 15 March 2022
Journal of Clinical Intensive Care and Medicine, Volume 7, pp 001-004; https://doi.org/10.29328/journal.jcicm.1001040
Introduction: Tuberculosis (TB) continues to pose a significant public health problem worldwide. Tuberculous meningitis (TBM) is the most devastating form of extrapulmonary TB however other forms of central nervous system (CNS) disease include tuberculoma and spinal arachnoiditis. TBM carries high mortality even for a patient who is already receiving treatment. The difficulty in diagnosis often leads to a delay in treatment and subsequent mortality. The emergence of Xpert ultra has improved the rapid detection of MTB and rifampicin resistance in CSF and is the preferred diagnostic tool in TBM. Case: In this case report we present a 33years patient of concern who presented with progressive lower limb weakness associated with pain and paresthesia for 4 months, admitted via the Orthopedic unit with a diagnosis of spinal mass (meningioma, neurofibroma, or nerve sheath tumor) for which biopsy was done and revealed a chronic inflammatory process, necrotic bone lesions with no granulomas and no malignancy, he was later diagnosed with tuberculous meningitis and promptly started anti-tuberculous therapy with a dramatic recovery and improvement in neurological function. Conclusion: Tuberculous meningitis conditions have high morbidity and mortality yet diagnosis and start of treatment continue to experience an important delay. Clinicians should keep in mind the limitations of clinical presentation due to pleiotropy and current diagnostics and should employ a combination of diagnostic modalities in addition to a high index of suspicion to prevent morbidity in patients with TBM.
Published: 15 October 2021
Journal of Clinical Intensive Care and Medicine, Volume 6, pp 033-037; https://doi.org/10.29328/journal.jcicm.1001039
Background: Varied clinical manifestations, complex pathogenesis, and different viral serotypes make it difficult to predict the course of dengue disease. Many studies have been conducted on the prognostic factors for the occurrence of dengue shock syndrome (SSD), but all use the 2017 World Health Organization (WHO) guidelines. Aim: This study aims to determine the prognostic factors for the occurrence of SSD based on WHO guidelines in 2011. Method: Retrospective study using medical record data of pediatric patients aged 0 to <18 years with a diagnosis of dengue fever dengue (DHF), SSD, and expanded dengue syndrome (EDS) that meet WHO criteria in 2011 at the reputable database from 2017 to December 2020. Independent variables, namely gender, age, nutritional status, secondary dengue infection, leukopenia, abdominal pain, gastrointestinal bleeding, hepatomegaly, and plasma leakage. Shock is the dependent variable. Multivariate analysis using logistic regression analysis. Results: Subjects who met the study criteria were 145 patients, 52 (35.8%) of whom had SSD. Five of 52 SSD patients went into shock during hospitalization. The bivariate analysis yielded significant factors including, malnutrition, overnutrition and obesity, gastrointestinal bleeding, hemoconcentration, ascites, leukocytes 5,000 mm 3, encephalopathy, enzyme elevation heart, and overload. The results of multivariate analysis showed that hemoconcentration variables and elevated liver enzymes were factors of SSD Prognosis. Conclusion: Hemoconcentration and elevated liver enzymes are prognostic factors for SSD.
Published: 17 August 2021
Journal of Clinical Intensive Care and Medicine, Volume 6, pp 021-025; https://doi.org/10.29328/journal.jcicm.1001036
Background: The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak severely hit Northeastern France from March to May 2020. The massive arrival of SARS-CoV-2 positive patients in the intensive care units (ICU) raised the question of how immunocompromised patients would be affected. Therefore, we analyzed the clinical, biological and radiological features of 24 immunocompromised ICU patients with severe SAR-CoV-2 infection. Results: The mortality rate was significantly higher for immunocompromised patients compared with other patients (41.7% versus 27.3%, respectively, p = 0.021). Mortality occurred in the first 2 weeks of intensive care, highlighting the possible interest in prolonged full-code managnement of these patients. Finally, patients with lymphoid malignancies appeared to be particularly affected, mostly with monoclonal gamma-pathology. Conclusion: Mortality rate of SARS-CoV-2 acute respiratory syndrome in immuno-compromised patient is high. No treatment was associated with survival improvement. Prolonged full-code management is required for these patients.
Published: 8 September 2021
Journal of Clinical Intensive Care and Medicine, Volume 6, pp 029-032; https://doi.org/10.29328/journal.jcicm.1001038
Familial dysautonomia is a rare autosomal recessive neurodegenerative disease affecting cells of the autonomic nervous system. Patients with this disease are insensitive to pain but their autonomic nervous system is still activated with noxious stimuli. This report details a case of a patient with familial dysautonomia who underwent right ankle open reduction and internal fixation for a bimalleolar right ankle fracture. The patients preoperative and intraoperative course were uneventful but shortly after handoff to the intensive care unit, the patient experienced an autonomic crisis. Management of these patients is complex, requiring maintenance of physiologic homeostasis as well as preventing hemodynamic instability caused by noxious stimuli. Any deviations from baseline may cause an autonomic crisis, as happened in our patient. Herein, we detail the perioperative management of a patient with familial dysautonomia in further detail.
Published: 10 August 2021
Journal of Clinical Intensive Care and Medicine, Volume 6, pp 015-020; https://doi.org/10.29328/journal.jcicm.1001035
Background: Delirium is an acute syndrome of organ dysfunction with long-term consequences which commonly occurs in the Intensive Care Unit (ICU). The incidence of delirium ranges from 30% - 50% in low severity ICU patients and up to 80% in mechanically ventilated patients. This condition is frequently under-recognized and daily routine screening is a key strategy to early intervention. The Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) and the Intensive Care Delirium Screening Checklist (ICDSC) are the most recommended assessment tools for detecting delirium in the critical ill patient. Objective: The main objective of this study is to educate ICU staff about delirium. In addition, nurses were trained to use the CAM-ICU as a standard screening tool. The intervention was evaluated through a survey aimed at ICU staff. Methods: An educational intervention was started in 2014 in our ICU. An educational package for ICU staff consisted of a didactic brochure and explanatory videos. One-on-one teaching, case based scenarios and didactic teaching were strategies used in the implementation process. The entire intervention was evaluated by means of a survey directed to the professionals. Results: The structure of the didactic brochure was simple in order to have an easy understanding of the CAM-ICU tool. We also created 10-minute videos. According to the results of the satisfaction survey (N=62), disorganized thinking was the most difficult feature of CAM-ICU to interpret. When in doubt, consultation between co-workers was the primary resource selected by unit staff. Conclusion: This initiative achieved the objective of training health care professionals in the application of the CAM-ICU tool with a good level of satisfaction from them. Therefore, ICU staff consider delirium management in the broader picture of critically ill patient care as a major activity of daily practice.
Published: 27 July 2021
Journal of Clinical Intensive Care and Medicine, Volume 6, pp 009-014; https://doi.org/10.29328/journal.jcicm.1001034
For the millions of patients experiencing chronic pain despite pharmacotherapy, deep brain stimulation (DBS) provides a beacon of hope. Over the past decade the field has shifted away from DBS towards other forms of neuromodulation, particularly spinal cord stimulation (SCS). DBS for pain is still performed, albeit off-label in US and UK, and experiences variable success rates. SCS is an extremely useful tool for the modulation of pain but is limited in its application to specific pain aetiologies. We advocate use of DBS for pain, for patients for whom pharmacology has failed and for whom spinal cord stimulation is inadequate. DBS for chronic pain is at risk of premature neglect. Here we outline how this has come to pass, and in the process argue for the untapped potential for this procedure.
Published: 23 August 2021
Journal of Clinical Intensive Care and Medicine, Volume 6, pp 026-028; https://doi.org/10.29328/journal.jcicm.1001037
Assessment of the microbial load of the operating environment during daily pre-, intra-, and post-operative procedures in a surgical department of a military emergency hospital in Bucharest showed the bacterial contamination of intra-operative air by increasing the number of bacteria above the allowed maximum level and the detection of a strain of Escherichia coli (E. coli).
Published: 26 April 2021
Journal of Clinical Intensive Care and Medicine, Volume 6, pp 006-008; https://doi.org/10.29328/journal.jcicm.1001033
Introduction: The contents of the retropharyngeal space are limited to fat and retropharyngeal nodes. Primary tumors originating from the retropharyngeal space are rare, therefore, the existence of schwannoma in the retropharyngeal space is infrequent. Method: This paper describes a case of a large schwannoma of the retropharyngeal space excised transorally with the use of co2 laser. This lesion measured about 6/6 x 3/5. Result: No peri-or post-operative complications were encountered. The procedure allowed quick resumption of an oral diet and a return to normal activity for the patient. Conclusion: This is, to our knowledge, the first report of this technique used in the excision of a large retropharyngeal space schwannoma.
Published: 13 April 2021
Journal of Clinical Intensive Care and Medicine, Volume 6, pp 001-005; https://doi.org/10.29328/journal.jcicm.1001032
Published: 29 May 2020
Journal of Clinical Intensive Care and Medicine, Volume 5, pp 020-021; https://doi.org/10.29328/journal.jcicm.1001030
Published: 3 June 2020
Journal of Clinical Intensive Care and Medicine, Volume 5, pp 022-025; https://doi.org/10.29328/journal.jcicm.1001031
Published: 19 May 2020
Journal of Clinical Intensive Care and Medicine, Volume 5, pp 015-019; https://doi.org/10.29328/journal.jcicm.1001029
Published: 12 March 2020
Journal of Clinical Intensive Care and Medicine, Volume 5, pp 001-006; https://doi.org/10.29328/journal.jcicm.1001027
Published: 12 December 2019
Journal of Clinical Intensive Care and Medicine, Volume 4, pp 044-047; https://doi.org/10.29328/journal.jcicm.1001026
Published: 12 December 2019
Journal of Clinical Intensive Care and Medicine, Volume 4, pp 042-043; https://doi.org/10.29328/journal.jcicm.1001025
Published: 22 August 2019
Journal of Clinical Intensive Care and Medicine, Volume 4, pp 040-041; https://doi.org/10.29328/journal.jcicm.1001024
Published: 22 July 2019
Journal of Clinical Intensive Care and Medicine, Volume 4, pp 036-039; https://doi.org/10.29328/journal.jcicm.1001023
Published: 2 May 2019
Journal of Clinical Intensive Care and Medicine, Volume 4, pp 028-036; https://doi.org/10.29328/journal.jcicm.1001022
Published: 19 April 2019
Journal of Clinical Intensive Care and Medicine, Volume 4, pp 023-027; https://doi.org/10.29328/journal.jcicm.1001021
Published: 24 January 2019
Journal of Clinical Intensive Care and Medicine, Volume 4, pp 001-009; https://doi.org/10.29328/journal.jcicm.1001018
Published: 7 February 2019
Journal of Clinical Intensive Care and Medicine, Volume 4, pp 018-022; https://doi.org/10.29328/journal.jcicm.1001020
Published: 4 February 2019
Journal of Clinical Intensive Care and Medicine, Volume 4, pp 010-017; https://doi.org/10.29328/journal.jcicm.1001019
Published: 31 October 2018
Journal of Clinical Intensive Care and Medicine, Volume 3, pp 029-034; https://doi.org/10.29328/journal.jcicm.1001017
Published: 27 October 2018
Journal of Clinical Intensive Care and Medicine, Volume 3, pp 027-028; https://doi.org/10.29328/journal.jcicm.1001016
Published: 17 October 2018
Journal of Clinical Intensive Care and Medicine, Volume 3, pp 023-026; https://doi.org/10.29328/journal.jcicm.1001015
Published: 15 October 2018
Journal of Clinical Intensive Care and Medicine, Volume 2, pp 020-022; https://doi.org/10.29328/journal.jcicm.1001014
Published: 16 March 2018
Journal of Clinical Intensive Care and Medicine pp 010-012; https://doi.org/10.29328/journal.jcicm.1001012
Published: 1 January 2018
Journal of Clinical Intensive Care and Medicine, Volume 2, pp 040-041; https://doi.org/10.29328/journal.jcicm.1001008
Published: 11 September 2018
Journal of Clinical Intensive Care and Medicine, Volume 3, pp 013-019; https://doi.org/10.29328/journal.jcicm.1001013
Published: 23 January 2018
Journal of Clinical Intensive Care and Medicine, Volume 3, pp 001-009; https://doi.org/10.29328/journal.jcicm.1001011